By Daniel Siegal ( August 11, 2015, 10:22 PM EDT) -- Days after Eli Lilly & Co. defeated claims it concealed the withdrawal risks of its antidepressant Cymbalta in a bellwether trial, the company found itself facing off against the same attorneys in a California federal courtroom as the trial of a second Cymbalta user opened....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.